| 000 | 01868 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516212323.0 | ||
| 264 | 0 | _c20150127 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.1699 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGraham, Regina M | |
| 245 | 0 | 0 |
_aInhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis. _h[electronic resource] |
| 260 |
_bOncotarget _cMar 2014 |
||
| 300 |
_a1162-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aButadienes _xpharmacology |
| 650 | 0 | 4 | _aCell Hypoxia |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 | _aHeterografts |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 |
_aMacrolides _xpharmacology |
| 650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aNitriles _xpharmacology |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 |
_aVacuolar Proton-Translocating ATPases _xantagonists & inhibitors |
| 700 | 1 | _aThompson, John W | |
| 700 | 1 | _aWebster, Keith A | |
| 773 | 0 |
_tOncotarget _gvol. 5 _gno. 5 _gp. 1162-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.1699 _zAvailable from publisher's website |
| 999 |
_c23809692 _d23809692 |
||